Adaptive Biotechnologies
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADPT and other ETFs, options, and stocks.About ADPT
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines.
ADPT Key Statistics
Stock Snapshot
As of today, Adaptive Biotechnologies(ADPT) shares are valued at $23.00. The company's market cap stands at 3.58B, with a P/E ratio of -68.33.
On 2026-07-01, Adaptive Biotechnologies(ADPT) stock moved within a range of $20.90 to $23.00. With shares now at $23.00, the stock is trading +10.0% above its intraday low and 0.0% below the session's peak.
Trading volume for Adaptive Biotechnologies(ADPT) stock has reached 3.28M, versus its average volume of 4.81M.
The stock's 52-week range extends from a low of $9.96 to a high of $23.00.
The stock's 52-week range extends from a low of $9.96 to a high of $23.00.
ADPT News
...
Adaptive Biotechnologies (ADPT) is back in focus after announcing plans to separate its Minimal Residual Disease and Immune Medicine businesses, alongside compl...
Guggenheim raised the firm’s price target on Adaptive Biotechnologies (ADPT) to $22 from $21 and keeps a Buy rating on the shares. The firm adjusted models and...
Analyst ratings
88%
of 8 ratingsMore ADPT News
Earlier in June 2026, Adaptive Biotechnologies completed a US$300,000,000 zero-coupon, senior unsecured convertible notes offering due July 1, 2031, shortly aft...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.